Intuitive Surgical, Inc. (ISRG)

Over the past six months, ISRG's stock price has been influenced by several events. Strong third-quarter earnings in October 2025 positively impacted the stock, but a lower-than-expected 2026 procedure growth guidance in January 2026 triggered a sell-off. The FDA clearance for cardiac procedures on the da Vinci 5 system on January 26, 2026, was a positive development. However, the stock experienced a decline in early February 2026 due to institutional selling, and Wall Street Zen lowered Intuitive Surgical's rating to "Hold".

Intuitive Surgical's products and services are industry-leading and in-demand, generating robust cash flow. The company has experienced strong demand for its da Vinci 5 systems and an increase in overall procedure volume, indicating consistent underlying demand for its innovative surgical solutions.

Intuitive Surgical, Inc. specializes in robotic-assisted, minimally invasive surgery. The company develops, manufactures, and markets robotic products, including the da Vinci Surgical System and the Ion endoluminal system, along with related instrumentation and support services. Its technologies are applied across various surgical specialties.

Intuitive Surgical has a global presence, marketing its products through direct sales and distributors across North America, South America, Europe, Asia-Pacific, the Middle East, and Africa. The company also operates offices in Europe and Asia-Pacific and has placed over 10,000 da Vinci systems globally.

Intuitive Surgical has a strong brand reputation due to its market leadership in robotic-assisted minimally invasive surgery. The da Vinci systems are recognized for their precision and innovation, supported by a robust patent portfolio and commitment to research and development. The company announced that 20 million patients had benefited from da Vinci surgery globally, further solidifying its positive impact.

Intuitive Surgical, Inc. has a significant institutional ownership base, with 3,191 institutional owners and shareholders holding a total of 335,534,593 shares. Major institutional owners include Vanguard Group Inc., BlackRock, Inc., and State Street Corp. Insiders collectively own 0.70% of the company's stock.